The National Task Force on Covid-19 under the Ministry of Health and Family Welfare has published revised clinical guidelines for the management of adults suffering from corona. According to the National Task Force, the revised guidelines recommend not using drugs such as lopinavir-ritonavir, hydroxychloroquine (HCQ), ivermectin, molanupiravir, favipiravir, azithromycin and doxycycline.
The National Monitoring Group on COVID-19 has advised against the use of plasma therapy for the treatment of adult COVID-19 patients. The National Task Force, headed by Vinod Paul, Member (Health), NITI Aayog, includes officials from the Indian Council of Medical Research (ICMR), Directorate General of Health Services and All India Institute of Medical Sciences (AIIMS). The task force last met on January 5 to review the Clinical Guidelines Protocol for the Treatment of Adult Patients.
Also read: 76 cases of new form of Kovid XBB 1.16 found in India, INSACOG data surfaced